RainforestMD Information

RainforestMD engineers plant-based topical therapeutics with a science-first platform: a bioactive knowledge library, an AI-driven modeling engine, and precision targeting of the inflammatory pathways that matter. Our first mission is atopic dermatitis (eczema) — a “common” condition that still wrecks sleep, comfort, and family quality of life. For decades, the default answer has been topical corticosteroids (TCS). They work, but chronic use carries well-documented side effects. Families deserve rigorously designed non-steroidal alternatives. We use computational chemistry and AI to predict molecular synergies before synthesis — so formulation isn’t mix-and-hope. Unique bioactives. Innovative modeling. One purpose: a new path to relieve real suffering. Early clinical work on our lead AD topical is encouraging and early. We’re backed by DMV Angels and building in public for patients, clinicians, and partners who care about better options in dermatology.